Loading…

efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models

In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated th...

Full description

Saved in:
Bibliographic Details
Published in:World journal of microbiology & biotechnology 2009-04, Vol.25 (4), p.679-686
Main Authors: Koley, Hemanta, Barman, Soumik, Roy, Nivedita, Saha, Dhira Rani, Kumar, Ranajit
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3
cites cdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3
container_end_page 686
container_issue 4
container_start_page 679
container_title World journal of microbiology & biotechnology
container_volume 25
creator Koley, Hemanta
Barman, Soumik
Roy, Nivedita
Saha, Dhira Rani
Kumar, Ranajit
description In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future.
doi_str_mv 10.1007/s11274-008-9937-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_36354766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1642212677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</originalsourceid><addsrcrecordid>eNqFkU-L1TAUxYso-Bz9AK4MguKmmty0SbOUwX8w4GKcdUjTm04ebfJM-kb67U3poOBiXAVyf-fk3Jyqesnoe0ap_JAZA9nUlHa1UlzW4lF1YK3kNVUSHlcHqlpV8zJ6Wj3L-UhpUSl-qO7QOW-NXYkJA_HzfA5xxOCtX1YSHTFk8ndIlmRCtjEcz6MJC7ld--QHksu1Dxt2fetHnCZDhjVjWDB5U0TrCQkjhVh-xeLvZzOROQ445efVE2emjC_uz4vq5vOnH5df66vvX75dfryqbSOapeYAErAxrB8sSlSNlR0XrRKqF7bpJXLROXQDCkDVOid4K1lLlYDe9U3X84vq7e57SvHnGfOiZ5_tljRgPGfNi6KRQvwXBMY5cN4V8N2DIBMNAAMhZUFf_4Me4zmFsq8GAAqdACgQ2yGbYs4JnT6l8lFp1YzqrVq9V6tLtXqrVm9h39wbm2zN5Eo51uc_wvI8cMo3DnYul1EYMf0N8JD5q13kTNRmTMX45hoo45QJCgoU_w0z0LzC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222028622</pqid></control><display><type>article</type><title>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</title><source>ABI/INFORM Global</source><source>Springer Nature</source><creator>Koley, Hemanta ; Barman, Soumik ; Roy, Nivedita ; Saha, Dhira Rani ; Kumar, Ranajit</creator><creatorcontrib>Koley, Hemanta ; Barman, Soumik ; Roy, Nivedita ; Saha, Dhira Rani ; Kumar, Ranajit</creatorcontrib><description>In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future.</description><identifier>ISSN: 0959-3993</identifier><identifier>EISSN: 1573-0972</identifier><identifier>DOI: 10.1007/s11274-008-9937-6</identifier><language>eng</language><publisher>Dordrecht: Dordrecht : Springer Netherlands</publisher><subject>Animal models ; Animals ; Applied Microbiology ; Bacterial infections ; Biochemistry ; Biological and medical sciences ; Biomedical and Life Sciences ; Biosynthesis ; Biotechnology ; Cholera ; Colon ; Developing countries ; Drug resistance ; Environmental Engineering/Biotechnology ; Epidemics ; Fundamental and applied biological sciences. Psychology ; Genes ; Immune response ; Immunization ; Immunogenicity ; Ketamine ; LDCs ; Life Sciences ; Mathematical analysis ; Mice ; Microbiology ; Original Paper ; Rabbits ; Salmonella ; Sanitation ; Serums ; Shigella ; Shigella dysenteriae ; Shigellosis ; Strain ; Studies ; Vaccines ; Virulence</subject><ispartof>World journal of microbiology &amp; biotechnology, 2009-04, Vol.25 (4), p.679-686</ispartof><rights>Springer Science+Business Media B.V. 2008</rights><rights>2009 INIST-CNRS</rights><rights>Springer Science+Business Media B.V. 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</citedby><cites>FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/222028622/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/222028622?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,11667,27901,27902,36037,36038,44339,74638</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21223036$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Koley, Hemanta</creatorcontrib><creatorcontrib>Barman, Soumik</creatorcontrib><creatorcontrib>Roy, Nivedita</creatorcontrib><creatorcontrib>Saha, Dhira Rani</creatorcontrib><creatorcontrib>Kumar, Ranajit</creatorcontrib><title>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</title><title>World journal of microbiology &amp; biotechnology</title><addtitle>World J Microbiol Biotechnol</addtitle><description>In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future.</description><subject>Animal models</subject><subject>Animals</subject><subject>Applied Microbiology</subject><subject>Bacterial infections</subject><subject>Biochemistry</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biosynthesis</subject><subject>Biotechnology</subject><subject>Cholera</subject><subject>Colon</subject><subject>Developing countries</subject><subject>Drug resistance</subject><subject>Environmental Engineering/Biotechnology</subject><subject>Epidemics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genes</subject><subject>Immune response</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Ketamine</subject><subject>LDCs</subject><subject>Life Sciences</subject><subject>Mathematical analysis</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Original Paper</subject><subject>Rabbits</subject><subject>Salmonella</subject><subject>Sanitation</subject><subject>Serums</subject><subject>Shigella</subject><subject>Shigella dysenteriae</subject><subject>Shigellosis</subject><subject>Strain</subject><subject>Studies</subject><subject>Vaccines</subject><subject>Virulence</subject><issn>0959-3993</issn><issn>1573-0972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNqFkU-L1TAUxYso-Bz9AK4MguKmmty0SbOUwX8w4GKcdUjTm04ebfJM-kb67U3poOBiXAVyf-fk3Jyqesnoe0ap_JAZA9nUlHa1UlzW4lF1YK3kNVUSHlcHqlpV8zJ6Wj3L-UhpUSl-qO7QOW-NXYkJA_HzfA5xxOCtX1YSHTFk8ndIlmRCtjEcz6MJC7ld--QHksu1Dxt2fetHnCZDhjVjWDB5U0TrCQkjhVh-xeLvZzOROQ445efVE2emjC_uz4vq5vOnH5df66vvX75dfryqbSOapeYAErAxrB8sSlSNlR0XrRKqF7bpJXLROXQDCkDVOid4K1lLlYDe9U3X84vq7e57SvHnGfOiZ5_tljRgPGfNi6KRQvwXBMY5cN4V8N2DIBMNAAMhZUFf_4Me4zmFsq8GAAqdACgQ2yGbYs4JnT6l8lFp1YzqrVq9V6tLtXqrVm9h39wbm2zN5Eo51uc_wvI8cMo3DnYul1EYMf0N8JD5q13kTNRmTMX45hoo45QJCgoU_w0z0LzC</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Koley, Hemanta</creator><creator>Barman, Soumik</creator><creator>Roy, Nivedita</creator><creator>Saha, Dhira Rani</creator><creator>Kumar, Ranajit</creator><general>Dordrecht : Springer Netherlands</general><general>Springer Netherlands</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7TB</scope><scope>7TK</scope><scope>7U5</scope><scope>7U9</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>L7M</scope><scope>LK8</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>7T5</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope></search><sort><creationdate>20090401</creationdate><title>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</title><author>Koley, Hemanta ; Barman, Soumik ; Roy, Nivedita ; Saha, Dhira Rani ; Kumar, Ranajit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Applied Microbiology</topic><topic>Bacterial infections</topic><topic>Biochemistry</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biosynthesis</topic><topic>Biotechnology</topic><topic>Cholera</topic><topic>Colon</topic><topic>Developing countries</topic><topic>Drug resistance</topic><topic>Environmental Engineering/Biotechnology</topic><topic>Epidemics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genes</topic><topic>Immune response</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Ketamine</topic><topic>LDCs</topic><topic>Life Sciences</topic><topic>Mathematical analysis</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Original Paper</topic><topic>Rabbits</topic><topic>Salmonella</topic><topic>Sanitation</topic><topic>Serums</topic><topic>Shigella</topic><topic>Shigella dysenteriae</topic><topic>Shigellosis</topic><topic>Strain</topic><topic>Studies</topic><topic>Vaccines</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koley, Hemanta</creatorcontrib><creatorcontrib>Barman, Soumik</creatorcontrib><creatorcontrib>Roy, Nivedita</creatorcontrib><creatorcontrib>Saha, Dhira Rani</creatorcontrib><creatorcontrib>Kumar, Ranajit</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Biological Sciences</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><jtitle>World journal of microbiology &amp; biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koley, Hemanta</au><au>Barman, Soumik</au><au>Roy, Nivedita</au><au>Saha, Dhira Rani</au><au>Kumar, Ranajit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models</atitle><jtitle>World journal of microbiology &amp; biotechnology</jtitle><stitle>World J Microbiol Biotechnol</stitle><date>2009-04-01</date><risdate>2009</risdate><volume>25</volume><issue>4</issue><spage>679</spage><epage>686</epage><pages>679-686</pages><issn>0959-3993</issn><eissn>1573-0972</eissn><abstract>In our earlier studies, we constructed a hybrid strain of Shigella dysenteriae type 1 by introducing a plasmid vector pPR 1347. After introduction of a lipopolysaccharide (LPS) biosynthesis gene, virulent Shigella dysenteriae type 1 strain became avirulent. In our present study, we have evaluated the immune response and protective efficacy of avirulent live transconjugant Shigella hybrid (LTSH) strain against wild type Shigella dysenteriae type 1, after four doses of oral (rabbit) and intranasal (mouse) immunizations. Serum IgG titers showed exponential increase during immunization and peaking on the 28th day and remained at that level till the 35th day in both the rabbit and the mouse models. When tested, serum IgG titers persisted for 63 days in mice and relatively high for 150 days in case of rabbits. Protection studies showed 100% protection against the challenge with wild type Shigella dysenteriae type 1 strain in rabbits and 80% protection in mice. Our results suggested that the LTSH strain could be a useful vaccine candidate strain in the future.</abstract><cop>Dordrecht</cop><pub>Dordrecht : Springer Netherlands</pub><doi>10.1007/s11274-008-9937-6</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-3993
ispartof World journal of microbiology & biotechnology, 2009-04, Vol.25 (4), p.679-686
issn 0959-3993
1573-0972
language eng
recordid cdi_proquest_miscellaneous_36354766
source ABI/INFORM Global; Springer Nature
subjects Animal models
Animals
Applied Microbiology
Bacterial infections
Biochemistry
Biological and medical sciences
Biomedical and Life Sciences
Biosynthesis
Biotechnology
Cholera
Colon
Developing countries
Drug resistance
Environmental Engineering/Biotechnology
Epidemics
Fundamental and applied biological sciences. Psychology
Genes
Immune response
Immunization
Immunogenicity
Ketamine
LDCs
Life Sciences
Mathematical analysis
Mice
Microbiology
Original Paper
Rabbits
Salmonella
Sanitation
Serums
Shigella
Shigella dysenteriae
Shigellosis
Strain
Studies
Vaccines
Virulence
title efficacy and immunogenicity of a live transconjugant hybrid strain of Shigella dysenteriae type 1 in two animal models
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A50%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=efficacy%20and%20immunogenicity%20of%20a%20live%20transconjugant%20hybrid%20strain%20of%20Shigella%20dysenteriae%20type%201%20in%20two%20animal%20models&rft.jtitle=World%20journal%20of%20microbiology%20&%20biotechnology&rft.au=Koley,%20Hemanta&rft.date=2009-04-01&rft.volume=25&rft.issue=4&rft.spage=679&rft.epage=686&rft.pages=679-686&rft.issn=0959-3993&rft.eissn=1573-0972&rft_id=info:doi/10.1007/s11274-008-9937-6&rft_dat=%3Cproquest_cross%3E1642212677%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-32272e4a1bdce7e94c78365969b6c4b7e368fefde62e95ff6357150962bfb48b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=222028622&rft_id=info:pmid/&rfr_iscdi=true